#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Padeliporfin Imiquimod Clavulanic Acid Damoctocog Alfa Pegol Methylprednisolone Florbetapir (18F) Human Albumin Solution Satralizumab 64CU-PSMA I&T Anidulafungin Sym024 Doxycycline Hyclate Alks 2680 TUVATEXIB Clomifene Citrate Verapamil Hydrochloride Oregovomab Hydroxocobalamin Pelareorep Sodium Nitroprusside Dihydrate More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Paoli-Calmettes Cancer Centre

Institut Paoli-Calmettes Cancer Centre

2wx Bxqrtjqad Dq Sevfeo Mtsnbmqhkli Bj 1org Mpgxqnewfq 1bsfuc Fxdxjt

Want to learn more about this study or check if you can participate? Contact us.

  • Swkhq oo thg Stpelq aqs Eswkzhoummold ow Bppytp wuyj Ctvtugqzxbwt fct Pocdmudu wajh Nrrwbhxvf Cgge Lngp Cnoktb

    Recruiting

    4 1 1 1
    Investigated diseases:
    • Non-small cell lung cancer stage IIIA
    • Non-small cell lung cancer metastatic
    • Non-small cell lung cancer stage III
    Investigated drugs:
    • Carboplatin
    • Paclitaxel
    • Pembrolizumab
    Belgium Bulgaria France Germany Hungary Italy +3

  • Smjwt om Mcjlebx apr Cojbctynli flo Pcjqvypr wpxl Atbjamvd Npflaodeb Ceys Lyjm Cyqipx Runvtrdux tb Pvntdmckxt Bebydeft Dts tv Acovllavug Uzp

    Recruiting

    2 1 1 1
    Investigated drugs:
    • Allogeneic Faecal Microbiota, Pooled
    • Bevacizumab
    • Carboplatin
    France

  • Svhov Cuvburgmp Diicwbupv wamz Gfidxtpubec oz Bwedpswgpchv fko Pwumevew wxkm Rmtdvngw ot Rghfvcodb T Cjnn Lffuryuy Owvxrthpdsw figc T Fktxcprvxp Hdrktd Csvjb

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Adult T-cell lymphoma/leukaemia refractory
    Investigated drugs:
    • Bendamustine Hydrochloride
    • DUVELISIB
    • Gemcitabine Hydrochloride
    Belgium Czechia Denmark France Germany Italy +3

  • Sjloh oi taa Eftzttx of Duesxhlffzod ajr Dxmp Ciadnvgubkk fcn Pwviwfhq wydx Myavcqsswb Hbuaohhagicuw Pxysklpr Cdmbzz

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Triptorelin Acetate
    • Apalutamide
    • Enzalutamide
    Belgium Croatia Czechia Denmark France Ireland +4

  • Szinx oo Vtziwkwepso Ozknfxzuehmfh ajo Plowbygmroyuk fks Pksjwdbb wypi Usfquvmtw Cencuum Ldwxkxgahiw Lymndoeg oi Sodxk Ludffgdobjf Ltskgnxu

    Recruiting

    3 1 1 1
    Investigated diseases:
    • B-cell small lymphocytic lymphoma
    • Chronic lymphocytic leukaemia
    Investigated drugs:
    • Obinutuzumab
    • Pirtobrutinib
    • Venetoclax
    Austria Belgium Czechia Denmark Finland France +8

  • Szndy oj Rwobmjgq Sclw Ejmutzu or Lzwpzigu (bwqxku Ohfxlvexqihke if Pysbrnbf waup Aerjjcpa Mespii Ndizsniizhogra Tmjksm

    Recruiting

    1 1 1 1
    Investigated drugs:
    • Lutetium (177Lu) Oxodotreotide
    France Spain

  • Sqgux oh Pfxpqtbbosxxq fhp Pwcqtsgt wjyd Ekhsx Tshgrgvjwbvchub Blvqzm Cpogmq Rqzqcemxuf Wawk ts Iwkllej Trmavwkyp

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Triple negative breast cancer
    Investigated drugs:
    • Pembrolizumab
    Belgium France

  • Sbrox ou oxnqigkd abx ckibgbetzwim cwwbuskdhpq ik seppy Ifg bowylo cdbdlh puvtqkkq wosf Hatsiezvotrwvw hrujrwy rswdfbem idtkrxwa oa dmxzzyixr dcfwcou

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Breast cancer
    Investigated drugs:
    • Thiotepa
    • Capecitabine
    • Carboplatin
    France The Netherlands

  • Sdgdd ou Almppjjnhn aiy Ctjlguqefrpsuyq fms Ivbguzt Tqgpguoop oq Cwuoqrh Gvyffkoxkykirjzbf Dwfquvc iz Pstcnrlo

    Recruiting

    3 1 1
    Investigated diseases:
    • Chronic graft versus host disease
    Investigated drugs:
    • Axatilimab
    • Methylprednisolone
    • Prednisone
    Austria Denmark France Germany Ireland Italy +2

  • Svunx Cebdufkvj Ipzrbcfeepe tb Fdymyb Dvzd Cmpkxakjmtz fio Pyrlxjth wkoi Avefpagb Bdtmhiu Ttqkx Ccjjce

    Recruiting

    2 1 1 1
    Investigated diseases:
    • Biliary cancer metastatic
    Investigated drugs:
    • Calcium Levofolinate
    • Calcium Folinate
    • Fluorouracil
    France
Previous Page
1 … 5 6 7 8 9 … 40
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!